Here's Why Doximity (DOCS) Fell More Than Broader Market

Core Insights - Doximity's stock closed at $65.61, down 9.59% from the previous session, underperforming compared to the S&P 500's loss of 2.71% [1] - The stock has increased by 3.29% over the past month, outperforming the Medical sector's gain of 2.6% but lagging behind the S&P 500's gain of 3.5% [1] Earnings Performance - Doximity is expected to report earnings of $0.38 per share, reflecting a year-over-year growth of 26.67% [2] - The consensus estimate for revenue is $157.73 million, indicating a 15.27% increase from the same quarter last year [2] - For the full year, analysts project earnings of $1.51 per share and revenue of $632.56 million, representing changes of +6.34% and +10.9% respectively from the previous year [3] Analyst Estimates - Recent changes in analyst estimates for Doximity are crucial as they reflect short-term business trends [4] - Positive estimate revisions are seen as a sign of optimism regarding the business outlook [4] Valuation Metrics - Doximity has a Forward P/E ratio of 48.18, which is higher than the industry average of 41.88 [7] - The company has a PEG ratio of 3.5, compared to the industry average PEG ratio of 3.32 [7] Industry Context - The Medical Info Systems industry, which includes Doximity, ranks in the bottom 41% of all industries according to the Zacks Industry Rank [8] - The Zacks Industry Rank indicates that the top 50% of rated industries outperform the bottom half by a factor of 2 to 1 [8]